Dr. Raghava Reddy Levaka Veera
Claim this profileGeisinger Wyoming Valley/Henry Cancer Center
Studies Lung Cancer
Studies Ovarian Cancer
19 reported clinical trials
43 drugs studied
About Raghava Reddy Levaka Veera
Education:
- Obtained MD from Kakatiya Medical College, Warangal, India (2009).
- Completed Residency in Internal Medicine at Geisinger Medical Center, Danville, PA (2015-2018).
- Undertook Fellowship in Hematology/Oncology at Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, PA (2018-2021).
Experience:
- Currently affiliated with Geisinger Wyoming Valley/Henry Cancer Center.
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Ovarian Cancer
Stage II
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Raghava Reddy Levaka Veera is currently running
Myopenia
for Colorectal Cancer
This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.
Recruiting1 award N/A6 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Raghava Reddy Levaka Veera
Clinical Trial Related5 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Raghava Reddy Levaka Veera has experience with
- Carboplatin
- Fluorouracil
- Capecitabine
- Intensity-Modulated Radiation Therapy
- Paclitaxel
- Pembrolizumab
Breakdown of trials Raghava Reddy Levaka Veera has run
Lung Cancer
Ovarian Cancer
Ovarian Carcinoma
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raghava Reddy Levaka Veera specialize in?
Raghava Reddy Levaka Veera focuses on Lung Cancer and Ovarian Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Raghava Reddy Levaka Veera currently recruiting for clinical trials?
Yes, Raghava Reddy Levaka Veera is currently recruiting for 2 clinical trials in Wilkes-Barre Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Raghava Reddy Levaka Veera has studied deeply?
Yes, Raghava Reddy Levaka Veera has studied treatments such as Carboplatin, Fluorouracil, Capecitabine.
What is the best way to schedule an appointment with Raghava Reddy Levaka Veera?
Apply for one of the trials that Raghava Reddy Levaka Veera is conducting.
What is the office address of Raghava Reddy Levaka Veera?
The office of Raghava Reddy Levaka Veera is located at: Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania 18711 United States. This is the address for their practice at the Geisinger Wyoming Valley/Henry Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.